ClinicalTrials.Veeva

Menu

Continuous Glucose Monitoring in Peri-operative Period in Kidney Transplant Recipients

Seoul National University logo

Seoul National University

Status

Enrolling

Conditions

New Onset Diabetes After Transplantation

Treatments

Diagnostic Test: continuous glucose monitoring

Study type

Observational

Funder types

Other

Identifiers

NCT06012799
SNUH-CGM-KT-V1.2

Details and patient eligibility

About

his study aims to utilize Continuous Glucose Monitoring (CGM) to observe glucose fluctuations in kidney transplant recipients and predict New-Onset Diabetes After Transplantation (NODAT) based on these patterns. Additionally, it seeks to investigate glucose variability resulting from medications and surgeries such as immunosuppressants and steroid regimens post-kidney transplantation. This prospective observational study anticipates identifying factors influencing blood glucose levels and contributing to future research on blood glucose management using CGM monitoring in kidney transplant patients.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The study will target 100 kidney transplant patients who have provided consent, among those who underwent the procedure at Seoul National University Hospital after March 2021.

Exclusion criteria

  • multi-organ transplant
  • history of previous kidney transplant
  • less than 18 years old

Trial contacts and locations

1

Loading...

Central trial contact

Jiyoung Sin, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems